[1]张静雯,吕艳艳,刘 洋,等.痹症1号对急性痛风性关节炎患者血清炎性因子水平变化的研究*[J].陕西中医,2019,(10):1411-1414.
 ZHANG Jingwen,LV Yanyan,LIU Yang,et al.Study on the changes of serum inflammatory factors of patientswith acute gouty arthritis treated with Bizheng No.1[J].,2019,(10):1411-1414.
点击复制

痹症1号对急性痛风性关节炎患者血清炎性因子水平变化的研究*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年10期
页码:
1411-1414
栏目:
临床研究
出版日期:
2019-10-05

文章信息/Info

Title:
Study on the changes of serum inflammatory factors of patientswith acute gouty arthritis treated with Bizheng No.1
文章编号:
DOI:10.3969/j.issn.10007369.2019.10.027
作者:
张静雯吕艳艳刘 洋邱红霞王 利刘 丹刘佳钰△
西安市第五医院风湿免疫科(西安 710082)
Author(s):
ZHANG JingwenLV YanyanLIU Yanget al.
Rheumatology Department,Xi’an No.5 Hospital (Xi’an 710082)
关键词:
急性痛风性关节炎痹症1号血尿酸肾小球滤过率白介素1β肿瘤坏死因子α基质金属蛋白酶9
Keywords:
Key words 〖HT5”SS〗Acute gouty arthritisBizheng No.1Blood uric acidGlomerular filtration rateInterleukin1βTumor necrosis factorαMatrix metalloprotein9
分类号:
R684.3
文献标志码:
A
摘要:
摘 要 目的:研究痹症1号联合洛索洛芬在急性痛风性关节炎患者血清中炎性因子水平变化及疗效观察。方法:将80例急性痛风性关节炎的患者,按照随机对照分为两组,每组40例。观察组给予痹症1号联合洛索洛芬治疗,对照组给予洛索洛芬单药治疗。连用10 d后,比较两组患者治疗前后一般临床指标\[血尿酸(BUA)、血肌酐(Scr)、血尿素氮(BUN)及肾小球滤过率eGFR\]和急性期的炎性指标(ESR、CRP、IL1β、TNFα及MMP9)的水平。结果:观察组的疗效明显高于对照组,差异有统计学意义(P< 0.05);两组炎性因子水平显著低于治疗前(均P< 0.05);治疗后的观察组炎性因子水平明显低于对照组,差异有统计学意义(均P< 0.05);治疗前后两组一般临床治疗指标无明显变化,差异无统计学意义(P> 0.05)。结论:痹症1号联合洛索洛芬能显著降低急性痛风性关节炎患者血清炎性因子的水平,其临床疗效与单独服用洛索洛芬相比较更好,能明显改善患者的关节症状,有利于其功能恢复。
Abstract:
Abstract 〖HT5”SS〗Objective:To discuss influence and curative effect observation of Bizheng No.1 combined with loxoprofen on serum inflammation in patients with acute gouty arthritis (AGA). Methods:80 cases of patients with AGA,were divided into observation group and control group according to the random number table method,40 cases in each group. The observation group was treated with Bizheng No.1 combined with loxoprofen,and the control group was treated with loxoprofen. At the same time,the two groups of patients were treated with lowsalt,lowfat,lowlow diet,plenty of drinking water,etc. After 10 days of continuous use,the general clinical indicators before and after treatment were compared between the two groups \[blood uric acid (BUA),serum creatinine (Scr),blood urea nitrogen (BUN) and glomerular filtration rate (eGFR) and acute phase inflammatory markers (ESR,CRP,IL1β,TNFα,and MMP9). Results:The therapeutic effect of the observation group was significantly better than that of the control group,and the difference was statistically significant (P<0.05). The levels of inflammatory factors in the two groups obviously declined than before treatment (P<0.05). After treatment,the level of the observation group was significantly lower. In the control group,the differences were statistically significant (P<0.05). There was no significant change in the general clinical treatment indexes between the two groups before and after treatment (P>0.05). Conclusion:Bizheng No.1 combined with loxoprofen can significantly reduce the levels of serum inflammation in patients with acute gouty arthritis,and the effect is not only be better than loxoprofen alone,but also improve the symptom and physical signs and it is favorable for the recovery of function of joint.

参考文献/References:

[1] Dalbeth N,Merriman TR,Stamp LK. Gout[J].Lancet,2016,388(10055):20392052.
[2] 王雯雯,吴华香.国内外痛风诊疗指南的比较与解析[J].浙江医学,2018,40(16):17751778.
[3] 戚子荣,丘青中,沈 玮,等.萆薢祛风饮联合洛索洛芬钠治疗湿热蕴结型急性痛风性关节炎的临床研究[J].广州中医药大学学报,2019,36(2):200204.
[4] 董伟光,赵娇娇,董玉山.中医药治疗痛风性关节炎研究进展[J].陕西中医,2015,36(4):505508.
[5] 〖JP4〗孙欣键.退癀消肿汤联合洛索洛芬钠片治疗急性痛风性关节炎的临床疗效及安全性[J].中医临床研究,2018,10(33):7475.
[6] Sidiropoulos PI,Goulielmos G,Voloudakis GK,et al..Inflammasomes and rheumatic diseases:evolving concepts[J].Ann Rheum Dis,2008,67(10):13821389.
[7] 曾小峰,陈耀龙.2016中国痛风诊疗指南[J].浙江医学,2017,39(21):18231832.
[8] 王靓怡,高明利,王丽敏,等.急性痛风性关节炎的中医治疗进展[J].风湿病与关节炎,2016,5(6):7376.
[9] 东 淳,沈 璐.从中医“治未病”思想浅议痛风的防治[J].陕西中医,2017,38(7):947948.
[10] 付盈悦,董龙聪,潘建翔,等.中医外治疗法与常规西药口服治疗急性痛风性关节炎网状Meta分析[J].中医药临床杂志,2019,31(1):94101.
[11] 武妤霞,郭 颖,刘 珊,等.周彩云教授论治痛风性关节炎急性期经验浅析[J].陕西中医,2017,38(5):654655.
[12] Saigal R,Agrawal A.Pathogenesis and Clinical Management of Gouty Arthritis[J].J Assoc Physicians India,2015,63(12):5663.
[13] Martinon F,Burns K,Tschopp J.The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proILbeta[J]. Mol Cell,2002,10(2):417426.
[14] Dinesh P,Rasool M. Berberine,an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats[J].Int Immunopharmacol,2017,44(1):2637.
[15] Hsieh MS,Ho HC,Chou DT,et al.Expression of matrix metalloproteinase9 (gelatinase B) in gouty arthritis and stimulation of MMP9 by urate crystals in macrophages[J]. J Cell Biochem,2003,89(4):791799.
[16] 陈海宏,高大伟,张会良,等.复方四黄液外敷治疗急性痛风性关节炎效果及对炎症反应指标的影响[J]. 中国老年学杂志,2018,38(3):641643.

相似文献/References:

[1]魏 薇,李鹏鸟,张向阳,等.关节肿痛散联合针刺治疗对急性痛风性关节炎患者滑膜及关节功能的影响[J].陕西中医,2022,(12):1801.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.038]
 WEI Wei,LI Pengniao,ZHANG Xiangyang,et al.Effects of Guanjie Zhongtong San combined with acupuncture on synovial function and joint function in patients with acute gouty arthritis[J].,2022,(10):1801.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.038]
[2]陈 佳,李 偲,王鸿雁.罗浮山风湿膏药外敷联合秋水仙碱片内服对急性痛风性关节炎患者血尿酸水平及促炎因子的影响[J].陕西中医,2023,(1):80.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.019]
 CHEN Jia,LI Cai,WANG Hongyan.Effect of external application of Luofu Shan rheumatism plaster combined with colchicine tablets on serum uric acid level and proinflammatory factors in patients with acute gouty arthritis[J].,2023,(10):80.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.019]
[3]郭 良,谭 昱,马春涛,等.四妙散加减治疗湿热蕴结型急性痛风性关节炎疗效及对患者T细胞亚群、血液流变学及炎性标志物的影响[J].陕西中医,2023,(2):199.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.014]
 GUO Liang,TAN Yu,MA Chuntao,et al.Effect of Simiao powder on T cell subsets,hemorheology and inflammatory markers in acute gouty arthritis of damp-heat accumulation type[J].,2023,(10):199.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.014]
[4]王赓丰,马俊福,邓雍钲,等.基于NF-κB通路探讨痛风汤对急性痛风性关节炎模型大鼠炎症的影响机制[J].陕西中医,2024,(6):740.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.004]
 WANG Gengfeng,MA Junfu,DENG Yongzheng,et al.Study on the mechanism of Tongfeng decoction on acute gouty arthritis model rats based on NF-κB pathway[J].,2024,(10):740.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.004]
[5]边卓琼,张 薇,姜 敏△,等.痹症1号联合醋氯芬酸片治疗湿热蕴结型急性痛风性关节炎疗效研究*[J].陕西中医,2019,(10):1415.

备注/Memo

备注/Memo:
*陕西省中医药管理局科研立项课题(2019ZZLC023)
更新日期/Last Update: 2019-10-23